Morphine-6-glucuronide

吗啡-6-葡萄糖苷酸

Report date: 2023/11/27 13:54:42
NME

Base Information

Drug NameMorphine-6-glucuronide
Drug Alias Name葡苷酸吗啡Glucuronide de morphineMorphini glucuronidum吗啡葡糖苷酸葡糖苷酸吗啡 +[11] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionMu opioid receptor agonists
TargetsMu opioid receptor
Therapy Area/IndicationsAcute PainPainPain, Postoperative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaPolandNetherlands +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCeNeS Pharmaceuticals plc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesPaion Uk LtdYichang Humanwell Pharmaceutical Co Ltd
Active IndicationsPain, Postoperative
Inactive IndicationsAcute PainPainAnesthesia

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG